Single and Multiple Ascending Dose Study of AMG 513 in Participants With Obesity
Public ClinicalTrials.gov record NCT06585462. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1, Randomized, Double-blind, Placebo-controlled, Single Ascending Dose and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 513 in Participants With Obesity
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to assess the safety and tolerability of AMG 513 after single and multiple doses.
Study identification
- NCT ID
- NCT06585462
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 82 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 9, 2024 (Actual)
- Primary completion
- Sep 16, 2026 (Actual)
- Completion
- Sep 16, 2026 (Actual)
- Last update posted
- Oct 6, 2026
2024 – 2026
United States locations
- U.S. sites
- 13
- U.S. states
- 6
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Anaheim Clinical Trials | Anaheim | California | 92801 | — |
| Orange County Research Center | Lake Forest | California | 92630 | — |
| Fomat Medical Research | Oxnard | California | 93030 | — |
| Translational Clinical Research LLC | Aventura | Florida | 33180 | — |
| Clinical Neuroscience Solutions - Jacksonville | Jacksonville | Florida | 32256 | — |
| South Florida Clinical Research Institute - Lauderhill | Lauderhill | Florida | 33351 | — |
| New Horizon Research Center | Miami | Florida | 33165 | — |
| Clinical Pharmacology of Miami, LLC | Miami | Florida | 33172 | — |
| Clinical Neuroscience Solutions | Orlando | Florida | 32801 | — |
| Rophe Adult and Pediatric Medicine/Sky Clinical Research Network Group | Union City | Georgia | 30291 | — |
| Prime Health and Wellness Sky Clinical Research Network Group | Fayette | Mississippi | 39069 | — |
| Lillestol Research LLC | Fargo | North Dakota | 58104 | — |
| Pinnacle Clinical Research | Austin | Texas | 78757 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06585462, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 6, 2026 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06585462 live on ClinicalTrials.gov.